OXIDATIVE DNA-DAMAGE IN CD34(-NECROSIS-FACTOR-ALPHA CONCENTRATION() MYELODYSPLASTIC CELLS IS ASSOCIATED WITH INTRACELLULAR REDOX CHANGES AND ELEVATED PLASMA TUMOR)
Cm. Peddie et al., OXIDATIVE DNA-DAMAGE IN CD34(-NECROSIS-FACTOR-ALPHA CONCENTRATION() MYELODYSPLASTIC CELLS IS ASSOCIATED WITH INTRACELLULAR REDOX CHANGES AND ELEVATED PLASMA TUMOR), British Journal of Haematology, 99(3), 1997, pp. 625-631
Ineffective haemopoiesis in the myelodysplastic syndromes (MDS) is med
iated, at least in part, by apoptosis, though the mechanisms of apopto
tic induction are unclear. Tumour necrosis factor-alpha (TNF-alpha) pr
omotes apoptosis via intracellular oxygen free radical production, oxi
dation of DNA and proteins, and is increasingly implicated in the path
ogenesis of MDS. Using single-cell gel electrophoresis, we have identi
fied oxidized pyrimidine nucleotides in the progenitor-enriched bone m
arrow CD34(+) compartment from MDS patients (P=0.039), which are absen
t in both CD34(-) MDS cells (P=0.53 and also CD34(+) cells from normal
subjects (P=0.55). MDS CD34(+) blood cells also showed oxidized pyrim
idine nucleotides compared with CD34(-) cells (P=0.029). Within normal
subjects no differences were seen between CD34(+) and CD34(-) bone ma
rrow cell compartments, CD34(+) bone marrow cell oxidized pyrimidines
were strongly associated with elevated plasma TNF-alpha and low bone m
arrow mononuclear cell glutathione concentrations (5/6 patients) and t
he inverse relationship was also found (3/4 patients), This data impli
es a role for intracellular oxygen free radical production, perhaps me
diated by TNF-alpha, in the pathogenesis of ineffective haemopoiesis i
n MDS and provides a rationale for the bone marrow stimulatory effects
of antioxidants such as Amifostine in MDS.